|Mr. Christopher Simon||CEO, Pres & Director||2.39M||N/A||1964|
|Mr. William P. Burke||CFO & Exec. VP||1.01M||222.28k||N/A|
|Ms. Michelle L. Basil||Exec. VP, Gen. Counsel & Sec.||1.01M||N/A||N/A|
|Ms. Jacqueline D. Scanlan||Sr. VP of Global HR||915.01k||N/A||N/A|
|Mr. Dan Goldstein||Principal Accounting Officer, VP & Corp. Controller||N/A||N/A||1977|
Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It offers automated plasma collection devices and related disposables, including NexSys PCS plasmapheresis system and PCS2 equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. The company also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, it offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, a surgical blood salvage system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; OrthoPAT, a perioperative autotranfusion system for orthopedic procedures; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.
Haemonetics Corporation’s ISS Governance QualityScore as of March 1, 2019 is 3. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 6; Compensation: 2.